All individuals in MeSH

Label Id Description
Drug Compounding D004339 [The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). ]
Drug Contamination D004340 [The presence of organisms, or any foreign material that makes a drug preparation impure. , The addition of less desirable substance to the drug preparation. , The presence of chemical substance other than the desired pharmaceutical compound manufactured. ]
Drug Costs D016527 [The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES). ]
Drug Delivery Systems D016503 [Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. ]
Drug Design D015195 [The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis. ]
Drug Development D000076722 [The entire process of bringing a new drug to the market. It includes both preclinical and clinical testing, and regulatory approval. ]
Drug Discovery D055808 [The process of finding chemicals for potential therapeutic use. ]
Drug Dosage Calculations D054796 [Math calculations done for preparing appropriate doses of medicines, taking into account conversions of WEIGHTS AND MEASURES. Mistakes are one of the sources of MEDICATION ERRORS. ]
Drug Elimination Routes D000084342 [Various processes through which administered drugs are discharged from the body. ]
Drug Eruptions D003875 [Dermatoid drug eruption characterized by widespread erythematous macules and papules often associated with a mild fever and itch. , Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. ]
Drug Evaluation D004341 [Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. ]
Drug Evaluation, Preclinical D004353 [Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. ]
Drug Hypersensitivity D004342 [Immunologically mediated adverse reactions to medicinal substances used legally or illegally. ]
Drug Hypersensitivity Syndrome D063926 [Severe drug eruption characterized by high fever, erythematous rash and inflammation of internal organ(s). ]
Drug Implants D004343 [Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. ]
Drug Incompatibility D004344 [The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed) ]
Drug Industry D004345 [That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. ]
Drug Information Services D004346 [Services providing pharmaceutic and therapeutic drug information and consultation. ]
Drug Interactions D004347 [The action of a drug that may affect the activity, metabolism, or toxicity of another drug. ]
Drug Inverse Agonism D054314 [Phenomena and pharmaceutics of compounds that bind to the same receptor binding-site as an agonist (DRUG AGONISM) for that receptor but exerts the opposite pharmacological effect. ]